{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Getting To A First Product Approval With Celcuity's Brian Sullivan","slug":"getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan","published_at":"2026-08-17T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19636491-getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19636491-getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approval for Revtorpyk, a kinase inhibitor for breast cancer patients, and why targeting an “untreated disease mechanism” can beat chasing a single mutation. Brian also discusses the process for licensing a shelved Pfizer asset for development, designing Phase 3 trials that challenge assumptions, the benefits of...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about win…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3016,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}